Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Humphrey J"'
Autor:
Joseph Omorogbe, Rana B. Haider, Niall Breslin, Sinead M. Smith, Grainne Holleran, Humphrey J. O'Connor, Denise Brennan, Barry Hall, Deirdre McNamara, Colm O'Morain
Publikováno v:
European Journal of Gastroenterology & Hepatology. 27:1265-1269
Eradication rates for the standard first-line triple therapy for Helicobacter pylori infection have decreased in recent years. Sequential therapy has been suggested as an alternative. The efficacy of sequential therapy has not been assessed to date i
Publikováno v:
European Journal of Gastroenterology & Hepatology. 26:819-825
Eradication rates of first-line triple therapy for Helicobacter pylori infection have fallen in the recent years. The main reasons for treatment failure are poor compliance due to complicated treatment regimens and the emergence of antibiotic-resista
Publikováno v:
Helicobacter. 16:33-37
Research published over the past year has documented the continued decline of Helicobacter pylori-related peptic ulcer disease and increased recognition of non-H. pylori, non-steroidal anti-inflammatory drugs ulcer disease--idiopathic ulcers. Despite
Autor:
Colm O'Morain, Anthony O'Connor, Asghar Qasim, A Nami, Philip Murphy, Niall Breslin, Niamh Fitzgerald, Barbara Ryan, Ikue Taneike, Humphrey J. O'Connor
Publikováno v:
European Journal of Gastroenterology & Hepatology. 22:1123-1127
Introduction Helicobacter pylori eradication rates have fallen considerably in recent years. Antibiotic resistance is thought to be rising. Objectives To examine the levels of resistance to metronidazole (MTZ) and clarithromycin (CLA) in H. pylori, i
Autor:
Ikue Taneike, Colm O'Morain, Asghar Qasim, Anthony O'Connor, A Nami, Philip Murphy, Humphrey J. O'Connor, N. Fitzgerald
Publikováno v:
Alimentary Pharmacology & Therapeutics. 30:784-790
Summary Background Helicobacter pylori infection is eradicated with antimicrobial agents and drug-resistant strains make successful treatment difficult. Geographical variations in virulence-factor genotype also exist. Aim To evaluate prevalence of dr
Publikováno v:
Irish Journal of Medical Science. 177:185-188
Since the discovery of Helicobacter pylori in the early 1980s several treatment regimens have been developed to effectively treat this infection. International guidelines have allowed consensus on the best management and improved eradication rates. I
Autor:
L. Brett Caram, Peter R. Kisenge, John Bartlett, Humphrey J. Shao, Nathan M. Thielman, John F. Shao, Dafrosa Itemba, Cindy A. Moylan, Susan C. Morpeth, John A. Crump, Habib O. Ramadhani, Keren Z. Landman, Noel E. Sam, Susanna Naggie
Publikováno v:
AIDS Research and Human Retroviruses. 23:1230-1236
Clinical criteria are recommended to select HIV-infected patients for initiation of antiretroviral therapy when CD4 lymphocyte testing is unavailable. We evaluated the performance characteristics of WHO staging criteria, anthropometrics, and simple l
Autor:
Shaji Sebastian, Orla Thornton, Mark J. Dobson, Humphrey J. O'Connor, Colm O'Morain, Ramona McLoughlin, Martin Buckley, Asghar Qasim
Publikováno v:
Alimentary Pharmacology and Therapeutics. 21:91-96
SUMMARY Background: Optimal management approach is not well defined for subjects who fail initial first- and second-line Helicobacter pylori eradication attempts and are dealt on a case-by-case basis by the specialists. Aim: To evaluate the efficacy
Publikováno v:
Helicobacter. 9:42-48
This represents an overview of the main data published over the last year on the therapy of Helicobacter pylori. The problem of increasing failure of H. pylori eradication has been the main focus, with increasing resistance and poor patient complianc
Publikováno v:
Alimentary Pharmacology & Therapeutics. 17:82-88
A 'test and treat' strategy is advocated for patients with dyspepsia under the age of 45 years, with endoscopy reserved for those with alarm symptoms or aged over 45 years. One of the consequences of this strategy will be a reduction in population in